Navigation Links
Leading University Hospital Completes System-Wide Conversion to Masimo SET(R) Pulse Oximetry

Standardizing on Masimo SET Allows Clinicians to Overcome the Limitations of Conventional Pulse Oximetry, Offering Significant Clinical Advancements

IRVINE, Calif., June 3 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion Pulse Oximetry, today announced it has completed the conversion of Duke University Hospital to Masimo SET pulse oximetry technology.

"Ultimately, the decision to convert to Masimo SET came down to what was best for patients," said Tony Caruso, Senior Director of Clinical Engineering, Duke University Health System in Durham, North Carolina. "It is critically important for us to access technologies that result in improvements in patient care. In this case, we believe we have improved our ability to increase detection of true clinical events earlier."

"In the emergency department, there are many times when we don't have time to second-guess our pulse oximeter performance, wonder whether the measurements we are getting are accurate, or take excessive time to obtain a reading," said Frank DeMarco, RN, emergency department clinical operations director, Duke University Hospital. "This technology offers us improvements over the system we had used previously and, hopefully, will contribute to more effective clinical operations."

Masimo Founder and CEO, Joe E. Kiani, stated, "We are happy to be the pulse oximetry standard-of-care solution chosen by the Duke University Hospital system to noninvasively and continuously monitor their patients. With the unprecedented accuracy and performance of Masimo SET, clinicians at Duke are afforded the opportunity to better monitor, manage and treat patients using advanced pulse oximetry capabilities that allow them to detect life-threatening events earlier."

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care--helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low-Perfusion pulse oximetry, known as Masimo SET(R), which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET(R) Pulse CO-OximetryTM, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHbTM), oxygen content (SpOCTM), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVITM, in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at

Forward Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumption that Masimo SET and Masimo Rainbow SET will deliver a sufficient level of clinical improvement over alternative pulse oximetry and noninvasive patient monitoring solutions to allow for further adoption of the technology at other hospitals, risks related to our assumption that Duke University Hospital's system-wide conversion to Masimo technology will serve to substantially increase revenues, as well as other factors discussed in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the fiscal quarter year ended April 4, 2009, filed with the Securities and Exchange Commission ("SEC") on May 6, 2009, which may be obtained for free at the SEC's website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our Quarterly Report on Form 10-Q for the fiscal quarter year ended April 4, 2009, filed with the Securities and Exchange Commission ("SEC") on May 6, 2009, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

    Dana Banks
    Masimo Corporation

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57,Rad-9, Rad-8, Rad-5,Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation. Other trademarks used herein are the property of their respective owners.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Leading Patient Advocacy Organizations United on Health Care Reform Principles
2., Leading Provider of Online Doctor Consultations, Launches New Website
3. MHPA, Leading Association Representing Medicaid Health Plans, Issues Statement on Proposed California SCHIP Elimination
4. Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants
5. Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region
6. Providence Service Corporation Rebuts False and Misleading Statements Contained in Proxy Statement Filed by the Avalon Group
7. Oridion Expands its Presence in the Pre-hospital Market with an OEM Partnership with a leading Defibrillator Manufacturer
8. Photos: The Nations Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research
9. New Reduced Subscription Rate to Leading International Journal on Blindness and Low Vision
10. Leading Alzheimers Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science
11. Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE
Post Your Comments:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
Breaking Medicine Technology: